KZIA logo

Kazia Therapeutics Limited American Depositary Shares


KZIA: Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing innovative anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors.


Show KZIA Financials

Consumer Interest
SEC Filings

Recent trades of KZIA by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by KZIA's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Functionalised benzopyran compounds and use thereof Aug. 06, 2019
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of KZIA in WallStreetBets Daily Discussion


Recent insights relating to KZIA

CNBC Recommendations

Recent picks made for KZIA stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in KZIA

Corporate Flights

Flights by private jets registered to KZIA